FDA Inspection
Apitoria Pharma Private LimitedApitoria Pharma Private Limited – FDA Inspection, Feb 2, 2019
Record Details
This FDA Inspection record concerns Apitoria Pharma Private Limited, with an inspection on February 2, 2019, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · 3aa5f215-66af-4a2f-b199-2533dae5e1d0
Inspection Facts
Official Action Indicated (OAI)
Significant objectionable conditions were found and regulatory or administrative action is recommended.
- Inspection number
- 1081175
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
Other FDA inspections of Apitoria Pharma Private Limited
4| Date | Classification | Office | Project area |
|---|---|---|---|
| November 18, 2022 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| May 10, 2018 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| March 5, 2015 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| June 20, 2012 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Apitoria Pharma Private Limited
- FDA Inspection 1192141 - 2022-11-18
- FDA Inspection 1063274 - 2018-05-10
- FDA Inspection 921426 - 2015-03-05
- FDA Inspection 792756 - 2012-06-20
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.